In metastatic melanoma, high CMTM6 and PD-L1 coexpression in the stromal compartment was highly correlated with longer survival in treated patients, while PD-L1 expression showed prognostic value in control patients (Martinez-Morilla et al., 2020). Here, CD274 is linked to metastatic melanoma.